A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Clinical trial NCT01621178 · COMPLETED
Trial details
- NCT number
- NCT01621178
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-06-01
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.